VITALIBIS, INC. Appoints Former Public Company CEO Dave Wentz To...

VITALIBIS, INC. Appoints Former Public Company CEO Dave Wentz To Advisory Board

Healthcare Tech Outlook | Friday, November 30, 2018

LAS VEGAS - VITALIBIS, INC. (OTC: VCBD), a technology based seller of premium, full spectrum phyto-cannabinoid rich (PCR) products, along with personal care and certified organic nutritional products, today announced the appointment of Dave Wentz to the Vitalibis Advisory Board. 

Dave helped found USANA Health Sciences, Inc. in 1992, and was instrumental in leading it to $1 billion in sales while serving over 1/2 million families. At USANA, Dave played many roles, including: VP of Strategic Development, Executive Vice President, President and CEO. USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products.

In January 2009, Dave was named by as one of Americas Powerful CEOs 40 and Under.  His focus on providing an exceptional workplace for employees worldwide led to Outside magazine naming USANA to its Best Places to Work list seven times.

Dave is also co-author of the New York Times best-selling book, The Healthy Home.  He has served as Chairman of the Direct Selling Association, and recently finished serving for the second time as Chairman of the Direct Selling Education Foundation. 

Steven Raack, CEO of Vitalibis, said, Daves leadership experience and strategic mindset are exceptional, but I also love that he cares about building a positive company culture.  Myself and the others on Team Vitalibis look forward to collaborating with and learning from Dave; a highly respected former CEO of a global, publicly traded health and wellness company.

Dave Wentz said, Ive had the great pleasure of working with Steve in the past and know the integrity, experience and knowledge he brings to an organization.  Vitalibis is in an exciting and fast growing business segment.  These two factors create a powerful combination that I am honored to be asked to play a part in and proud of the impact we will have on peoples health.

Weekly Brief